| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/23/2005 | EP1507855A2 Elongase genes and uses thereof |
| 02/23/2005 | EP1507780A1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors |
| 02/23/2005 | EP1507773A1 Macrocyclic compounds useful as pharmaceuticals |
| 02/23/2005 | EP1507765A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 02/23/2005 | EP1507760A1 Cyanoguanidine prodrugs |
| 02/23/2005 | EP1507758A2 Indole derivatives and their use as ligands for cb2 receptors |
| 02/23/2005 | EP1507756A1 Ccr9 inhibitors and methods of use thereof |
| 02/23/2005 | EP1507558A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 02/23/2005 | EP1507554A1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 02/23/2005 | EP1507543A1 A pharmaceutical composition for treatment of wounds containing blood plasma or serum |
| 02/23/2005 | EP1507539A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone |
| 02/23/2005 | EP1507537A1 Combination of an ace inhibitor, a calcium channel blocker and a diuretic |
| 02/23/2005 | EP1507535A1 Pyrimidine-2,4,6-trione metallo-proteinase inhibitors |
| 02/23/2005 | EP1507529A1 Combination of organic compounds |
| 02/23/2005 | EP1507528A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting |
| 02/23/2005 | EP1507524A1 Use of diuretics for treating swellings |
| 02/23/2005 | EP1507455A1 Antimicrobial envelopes |
| 02/23/2005 | EP1317421B1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/23/2005 | EP1274710B1 Novel heteroaryl-diazabicycloalkanes |
| 02/23/2005 | EP1133482B1 Il-5 inhibiting 6-azauracil derivatives |
| 02/23/2005 | EP1107962B1 Quinolin-2-one derivatives useful as anticancer agents |
| 02/23/2005 | CN1585763A Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |
| 02/23/2005 | CN1585754A Quinazoline derivatives as antitumor agents |
| 02/23/2005 | CN1585750A Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/23/2005 | CN1585749A Cannabinoid receptor ligands |
| 02/23/2005 | CN1585748A NK1 antagonists |
| 02/23/2005 | CN1585745A Hydroxyfattysulfonic acid analogs |
| 02/23/2005 | CN1585649A Method of improving wound healing |
| 02/23/2005 | CN1585648A Enamel matrix protein compositions for modulating immune response |
| 02/23/2005 | CN1585646A Strontium compound for treatment of sub-dermal soft tissue pain |
| 02/23/2005 | CN1585642A Pharmaceutical compositions containing 3, 4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 02/23/2005 | CN1585641A Hydrazono-malonitriles |
| 02/23/2005 | CN1585640A N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation |
| 02/23/2005 | CN1585633A Phenethanolamine derivatives for treatment of respiratory diseases |
| 02/23/2005 | CN1585629A Carotenoid composition and method for protecting skin |
| 02/23/2005 | CN1583175A Skin targeting medicinal composition and its preparation and use |
| 02/23/2005 | CN1583169A Use of human lysozyme in preparation of medicine for hemorrhoid |
| 02/23/2005 | CN1583168A Use of human lysozyme in preparation of medicine for unhealed ulceration by wound inflammation |
| 02/23/2005 | CN1583166A Chinese forest frog bactericidal peptide spray agent and its preparation |
| 02/23/2005 | CN1583165A Gel gent of Chiense forest frog bactericidal peptide |
| 02/23/2005 | CN1583162A Injection of donkey hide gelatin and its preparation |
| 02/23/2005 | CN1583153A Preparation and use of medicinal liquid for chilblain |
| 02/23/2005 | CN1583144A Chinese medicinal preparation for allergic reaction |
| 02/23/2005 | CN1583117A External used Chinese medicinal ointment for scald and its preparation |
| 02/23/2005 | CN1583110A Medicine for burn and scald and its preparation |
| 02/23/2005 | CN1583106A Chinese medicine for eliminating wrickle, acne, freckle, antianaphylaxis and beautifying |
| 02/23/2005 | CN1583092A Chinese medicinal composition for skin diseases |
| 02/23/2005 | CN1583067A Burn medicine and its preparation and use |
| 02/23/2005 | CN1583050A Dispersal tablets for treating sores by removing heat and their preparing method |
| 02/23/2005 | CN1583038A Skin bactericidal medicine and its preparation |
| 02/23/2005 | CN1583025A Burn and scald treating powder |
| 02/23/2005 | CN1583024A Medicine for treating wound |
| 02/23/2005 | CN1583006A Medicinal liquid for Hong Kong foot |
| 02/23/2005 | CN1583005A External used medicines for Hong Kong foot and tinea manuum |
| 02/23/2005 | CN1582996A Composite medicine for baldness |
| 02/23/2005 | CN1582992A Pollen and medicinal composition for cosmetics and its preparation |
| 02/23/2005 | CN1582986A Hair growth liniment |
| 02/23/2005 | CN1582982A Yishoudan for nourishing hair and face |
| 02/23/2005 | CN1582936A External used gel of Jiatishacin and its preparation |
| 02/23/2005 | CN1190491C PRV-gene and use thereof |
| 02/23/2005 | CN1190445C Process for producing functional silk fibroin and utilization of the same |
| 02/23/2005 | CN1190437C Pteridine compounds for treatment of psoriasis |
| 02/23/2005 | CN1190235C Process for preparing health-care compound sheep placenta extract food series |
| 02/23/2005 | CN1190232C Wart-removing ointment |
| 02/23/2005 | CN1190226C External used germinal pharmaceutics and preparation process thereof |
| 02/23/2005 | CN1190225C Oral preparation for hair-growing and its making process |
| 02/23/2005 | CN1190217C Medicine for treating dematosis |
| 02/23/2005 | CN1190203C Agent for promoting hair growth, preventing hair whitening and bald, and eliminating dandruff |
| 02/23/2005 | CN1190192C Capsule agent with grape-seed extracts as raw material |
| 02/22/2005 | US6858739 Indole and benzimidazole 15-lipoxygenase inhibitors |
| 02/22/2005 | US6858647 Administering retinoid such as, 6-(3-(1-Adamantyl)-4-methoxy-5-hydroxyphenyl)-2-naphthoic acid benzoic acid for therapy of and prophylaxis of bacterial infection |
| 02/22/2005 | US6858628 Substituted cyclic amine metalloprotease inhibitors |
| 02/22/2005 | US6858626 Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 02/22/2005 | US6858624 Comprises 5,8,14-triazatetracyclo(10.3.1.0.0)-hexadeca-2(11),3,5,7,9-penaene groups; for reducing drug addiction, treating Alzheimer's/Parkinson's diseases, and other nervous system disorders |
| 02/22/2005 | US6858621 Mbreast and prostate anticancer agents; viricides; alopecia |
| 02/22/2005 | US6858615 Phenyl guanidine sodium channel blockers |
| 02/22/2005 | US6858614 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for treating chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 02/22/2005 | US6858602 Compounds for the treatment of metabolic disorders |
| 02/22/2005 | US6858597 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 02/22/2005 | US6858581 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity |
| 02/22/2005 | US6858420 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/22/2005 | US6858235 Antioxidant composition and method of preparation thereof |
| 02/22/2005 | US6858232 Topical transdermal treatments |
| 02/22/2005 | US6858202 Detergent compositions with enhanced depositing, conditioning and softness capabilities |
| 02/22/2005 | CA2438055A1 Treatment of allergic rhinitis |
| 02/22/2005 | CA2236256C A pharmaceutical composition for the treatment of autoimmune diseases |
| 02/17/2005 | WO2005014614A1 Steroid derivatives and use thereof as medicaments |
| 02/17/2005 | WO2005014580A1 Pyridyl piperazinyl ureas |
| 02/17/2005 | WO2005014576A1 Isoquinolinone derivative, process for producing the same and use thereof |
| 02/17/2005 | WO2005014572A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | WO2005014567A1 Mycophenolic acid bismuth salt |
| 02/17/2005 | WO2005014012A1 New therapeutic use of chondroitin sulphate |
| 02/17/2005 | WO2005014003A1 Topical use of tyrosine kinase inhibitors of microbial origin to prevent and treat skin disorders characterised by excessive cell proliferation |
| 02/17/2005 | WO2005013986A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 02/17/2005 | WO2005013966A1 Macrophage activation inhibitor |
| 02/17/2005 | WO2005013932A1 Use of spermine and/or spermidine against skin ageting in dietary, pharmaceutical or cosmetic compositions |
| 02/17/2005 | WO2005013928A1 Composition and method for promoting hair growth |
| 02/17/2005 | WO2005000266A3 Liposomal formulations comprising a combination of two or more active agents |
| 02/17/2005 | WO2004101609A3 Cosmetic or dermopharmaceutical composition for reducing the signs of cutaneous ageing |